|  | Using the Ara and Brazier (2008) mapping [25] | Using the Rowen et al. (2009) mapping [26] | ||||
---|---|---|---|---|---|---|---|
Duration of residual benefit | Costing Source | Inc costs (£) | Inc QALY | Cost per QALY (£) (95 % CI) | Inc costs (£) | Inc QALY | Cost per QALY (£) (95 % CI) |
52 weeks | BAAT | −16 | 0.0675 | Dominating (Dominating–183a) | −16 | 0.0757 | Dominating (Dominating–99a) |
52 weeks | Curtis [28] | −22 | 0.0675 | Dominating (Dominating–251a) | −22 | 0.0757 | Dominating (Dominating–136a) |
104 weeks | BAAT | −16 | 0.1241 | Dominating (Dominating–168a) | −16 | 0.1391 | Dominating (Dominating–91a) |
104 weeks | Curtis [28] | −22 | 0.1241 | Dominating (Dominating–230a) | −22 | 0.1391 | Dominating (Dominating–125a) |